Cellectis SA, a French genome engineering company, will collaborate with Bayer CropScience to use its proprietary custom-made Meganuclease technology in plants to develop products for use in agriculture. Meganucleases are a genome engineering technology that allows highly precise 'editing' of genetic sequences. Celectis says that this high specificity ensures Meganucleases can bind and cut at a single point in a chosen genome, avoiding the imprecision associated with most other forms of gene modification. Custom-made Meganucleases can be designed for very specific gene targeting applications, which include genomic sequence addition, modification or deletion.

See Cellectis' press release at http://www.cellectis.com/news/clsinfo-gb-071106.html